Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Saint Mary's Regional Medical Center
mi
from
Reno, NV
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Saint Mary's Regional Medical Center
mi
from
Reno, NV
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Cancer Institute of New Jersey at Cooper University Hospital - Camden
mi
from
Camden, NJ
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Cancer Institute of New Jersey at Cooper University Hospital - Camden
mi
from
Camden, NJ
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Cancer Institute of New Jersey at Cooper - Voorhees
mi
from
Voorhees, NJ
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Cancer Institute of New Jersey at Cooper - Voorhees
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Lovelace Medical Center - Downtown
mi
from
Albuquerque, NM
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Lovelace Medical Center - Downtown
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Veterans Affairs Medical Center - Brooklyn
mi
from
Brooklyn, NY
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Veterans Affairs Medical Center - Brooklyn
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
New York Methodist Hospital
mi
from
Brooklyn, NY
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
New York Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Cancer Centers of North Carolina - Raleigh
mi
from
Raleigh, NC
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Cancer Centers of North Carolina - Raleigh
mi
from
Raleigh, NC
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Rex Cancer Center at Rex Hospital
mi
from
Raleigh, NC
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Rex Cancer Center at Rex Hospital
mi
from
Raleigh, NC
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Jean and Milton Cooper Cancer Center at Summa Akron City Hospital
mi
from
Akron, OH
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Jean and Milton Cooper Cancer Center at Summa Akron City Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Charles M. Barrett Cancer Center at University Hospital
mi
from
Cincinnati, OH
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Charles M. Barrett Cancer Center at University Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Precision Radiotherapy at University Pointe
mi
from
West Chester, OH
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Precision Radiotherapy at University Pointe
mi
from
West Chester, OH
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Cancer Treatment Center
mi
from
Wooster, OH
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Cancer Treatment Center
mi
from
Wooster, OH
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Cancer Center of Paoli Memorial Hospital
mi
from
Paoli, PA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Cancer Center of Paoli Memorial Hospital
mi
from
Paoli, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
MNAP Oncologic Center
mi
from
Philadelphia, PA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
MNAP Oncologic Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Albert Einstein Cancer Center
mi
from
Philadelphia, PA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Albert Einstein Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
mi
from
Reading, PA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
mi
from
Reading, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Mount Nittany Medical Center
mi
from
State College, PA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Mount Nittany Medical Center
mi
from
State College, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
CCOP - Main Line Health
mi
from
Wynnewood, PA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
CCOP - Main Line Health
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Lankenau Cancer Center at Lankenau Hospital
mi
from
Wynnewood, PA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Lankenau Cancer Center at Lankenau Hospital
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Thompson Cancer Survival Center
mi
from
Knoxville, TN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Thompson Cancer Survival Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Jon and Karen Huntsman Cancer Center at Intermountain Medical Center
mi
from
Murray, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Jon and Karen Huntsman Cancer Center at Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
mi
from
Ogden, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
mi
from
Ogden, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Dixie Regional Medical Center - East Campus
mi
from
Saint George, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Dixie Regional Medical Center - East Campus
mi
from
Saint George, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
LDS Hospital
mi
from
Salt Lake City, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Danville Regional Medical Center
mi
from
Danville, VA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Danville Regional Medical Center
mi
from
Danville, VA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Community Memorial Hospital Cancer Care Center
mi
from
Menomonee Falls, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Community Memorial Hospital Cancer Care Center
mi
from
Menomonee Falls, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
All Saints Cancer Center at Wheaton Franciscan Healthcare
mi
from
Racine, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
All Saints Cancer Center at Wheaton Franciscan Healthcare
mi
from
Racine, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Tom Baker Cancer Centre - Calgary
mi
from
Calgary,
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Tom Baker Cancer Centre - Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Wilford Hall Medical Center
mi
from
Lackland Air Force Base, TX
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Wilford Hall Medical Center
mi
from
Lackland Air Force Base, TX
Click here to add this to my saved trials
Staple vs. Suture in Robotic Prostatectomy
Endoscopic Stapling Versus Suture Ligation of Dorsal Venous Complex During Robot-Assisted Laparoscopic Prostatectomy: A Randomized Prospective Study
Status: Enrolling
Updated:  3/21/2018
Swedish Medical Center
mi
from
Seattle, WA
Staple vs. Suture in Robotic Prostatectomy
Endoscopic Stapling Versus Suture Ligation of Dorsal Venous Complex During Robot-Assisted Laparoscopic Prostatectomy: A Randomized Prospective Study
Status: Enrolling
Updated: 3/21/2018
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
A Phase II Trial of AZD0530 in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated:  3/21/2018
City of Hope
mi
from
Duarte, CA
AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
A Phase II Trial of AZD0530 in Hormone Refractory Prostate Cancer (HRPC)
Status: Enrolling
Updated: 3/21/2018
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
A Phase II Trial of Docetaxel, Thalidomide, Prednisone and Bevacizumab in Patients With Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  3/22/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
A Phase II Trial of Docetaxel, Thalidomide, Prednisone and Bevacizumab in Patients With Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 3/22/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
A Re-treatment Safety Study of Radium-223 Dichloride in Subjects With Castration-resistant Prostate Cancer With Bone Metastases Who Received an Initial Course of Six Doses of Radium-223 Dichloride 50 kBq/kg Every Four Weeks
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
New Orleans, LA
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
A Re-treatment Safety Study of Radium-223 Dichloride in Subjects With Castration-resistant Prostate Cancer With Bone Metastases Who Received an Initial Course of Six Doses of Radium-223 Dichloride 50 kBq/kg Every Four Weeks
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
A Re-treatment Safety Study of Radium-223 Dichloride in Subjects With Castration-resistant Prostate Cancer With Bone Metastases Who Received an Initial Course of Six Doses of Radium-223 Dichloride 50 kBq/kg Every Four Weeks
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Omaha, NE
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
A Re-treatment Safety Study of Radium-223 Dichloride in Subjects With Castration-resistant Prostate Cancer With Bone Metastases Who Received an Initial Course of Six Doses of Radium-223 Dichloride 50 kBq/kg Every Four Weeks
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
A Re-treatment Safety Study of Radium-223 Dichloride in Subjects With Castration-resistant Prostate Cancer With Bone Metastases Who Received an Initial Course of Six Doses of Radium-223 Dichloride 50 kBq/kg Every Four Weeks
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Syracuse, NY
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
A Re-treatment Safety Study of Radium-223 Dichloride in Subjects With Castration-resistant Prostate Cancer With Bone Metastases Who Received an Initial Course of Six Doses of Radium-223 Dichloride 50 kBq/kg Every Four Weeks
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Syracuse, NY
Click here to add this to my saved trials
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
A Re-treatment Safety Study of Radium-223 Dichloride in Subjects With Castration-resistant Prostate Cancer With Bone Metastases Who Received an Initial Course of Six Doses of Radium-223 Dichloride 50 kBq/kg Every Four Weeks
Status: Enrolling
Updated:  3/23/2018
mi
from
Kuopio,
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
A Re-treatment Safety Study of Radium-223 Dichloride in Subjects With Castration-resistant Prostate Cancer With Bone Metastases Who Received an Initial Course of Six Doses of Radium-223 Dichloride 50 kBq/kg Every Four Weeks
Status: Enrolling
Updated: 3/23/2018
mi
from
Kuopio,
Click here to add this to my saved trials
Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases
An Observation, Open Label Study of Alpharadin (Radium 223) in Patients With Castrate Resistant Prostate Cancer Bone Metastases
Status: Enrolling
Updated:  3/30/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases
An Observation, Open Label Study of Alpharadin (Radium 223) in Patients With Castrate Resistant Prostate Cancer Bone Metastases
Status: Enrolling
Updated: 3/30/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Abiraterone Acetate for Castrate Resistant Prostate Cancer
Investigator-Initiated, Pilot Translational Study of Circulating Tumor Cells to Identify Predictive Factors of Response to Abiraterone Acetate in Men With Castration-Resistant Prostate Cancer
Status: Enrolling
Updated:  4/3/2018
Massachusetts General Hospital
mi
from
Boston, MA
Abiraterone Acetate for Castrate Resistant Prostate Cancer
Investigator-Initiated, Pilot Translational Study of Circulating Tumor Cells to Identify Predictive Factors of Response to Abiraterone Acetate in Men With Castration-Resistant Prostate Cancer
Status: Enrolling
Updated: 4/3/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Maintaining Suppression of Testosterone With Transdermal Estradiol Gel
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BHR-200 (0.36% Transdermal Estradiol Gel) for the Maintenance of Testosterone Suppression in Men With Advanced Androgen-Sensitive Prostate Cancer
Status: Enrolling
Updated:  4/3/2018
Urological Associates of Southern Arizona, PC
mi
from
Tucson, AZ
Maintaining Suppression of Testosterone With Transdermal Estradiol Gel
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BHR-200 (0.36% Transdermal Estradiol Gel) for the Maintenance of Testosterone Suppression in Men With Advanced Androgen-Sensitive Prostate Cancer
Status: Enrolling
Updated: 4/3/2018
Urological Associates of Southern Arizona, PC
mi
from
Tucson, AZ
Click here to add this to my saved trials
Maintaining Suppression of Testosterone With Transdermal Estradiol Gel
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BHR-200 (0.36% Transdermal Estradiol Gel) for the Maintenance of Testosterone Suppression in Men With Advanced Androgen-Sensitive Prostate Cancer
Status: Enrolling
Updated:  4/3/2018
South Florida Medical Research
mi
from
Aventura, FL
Maintaining Suppression of Testosterone With Transdermal Estradiol Gel
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BHR-200 (0.36% Transdermal Estradiol Gel) for the Maintenance of Testosterone Suppression in Men With Advanced Androgen-Sensitive Prostate Cancer
Status: Enrolling
Updated: 4/3/2018
South Florida Medical Research
mi
from
Aventura, FL
Click here to add this to my saved trials
Maintaining Suppression of Testosterone With Transdermal Estradiol Gel
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BHR-200 (0.36% Transdermal Estradiol Gel) for the Maintenance of Testosterone Suppression in Men With Advanced Androgen-Sensitive Prostate Cancer
Status: Enrolling
Updated:  4/3/2018
Delaware Valley Urology, LLC
mi
from
Voorhees, NJ
Maintaining Suppression of Testosterone With Transdermal Estradiol Gel
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BHR-200 (0.36% Transdermal Estradiol Gel) for the Maintenance of Testosterone Suppression in Men With Advanced Androgen-Sensitive Prostate Cancer
Status: Enrolling
Updated: 4/3/2018
Delaware Valley Urology, LLC
mi
from
Voorhees, NJ
Click here to add this to my saved trials